NASDAQ:PLSE - Pulse Biosciences Stock Price, Forecast & News

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

Pulse Biosciences Inc (NASDAQ:PLSE) issued its earnings results on Thursday, November, 7th. The company reported ($0.57) EPS for the quarter, beating analysts' consensus estimates of ($0.61) by $0.04. View Pulse Biosciences' Earnings History.

Pulse Biosciences is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Pulse Biosciences.

1 Wall Street analysts have issued 1-year price objectives for Pulse Biosciences' shares. Their forecasts range from $27.00 to $27.00. On average, they anticipate Pulse Biosciences' share price to reach $27.00 in the next year. This suggests a possible upside of 89.3% from the stock's current price. View Analyst Price Targets for Pulse Biosciences.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Pulse Biosciences.

Media coverage about PLSE stock has been trending somewhat negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pulse Biosciences earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Pulse Biosciences.

Some companies that are related to Pulse Biosciences include Cryolife (CRY), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX), Orthofix Medical (OFIX), Orthopediatrics (KIDS), Intersect ENT (XENT), MiMedx Group (MDXG), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), AngioDynamics (ANGO), SurModics (SRDX) and SI-Bone (SIBN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Energous (WATT), Advanced Micro Devices (AMD), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), AbbVie (ABBV), Fate Therapeutics (FATE), Portola Pharmaceuticals (PTLA), Roku (ROKU) and Exelixis (EXEL).

(PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

Pulse Biosciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Steward Partners Investment Advisory LLC (0.01%). View Institutional Ownership Trends for Pulse Biosciences.

PLSE stock was sold by a variety of institutional investors in the last quarter, including Steward Partners Investment Advisory LLC. View Insider Buying and Selling for Pulse Biosciences.

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PLSE stock can currently be purchased for approximately $14.26.

Pulse Biosciences has a market capitalization of $296.47 million. The company earns $-37,540,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Pulse Biosciences employs 54 workers across the globe.View Additional Information About Pulse Biosciences.

The official website for Pulse Biosciences is http://www.pulsebiosciences.com/.

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]